Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hirayama

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
Thrombosis and Haemostasis|April 8, 1998
Biochemical and pharmacological characterization of YM-60828, a newly synthesized and orally active inhibitor of human factor XaY Taniuchi, Y Sakai, N Hisamichi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1984
[Phase II study of mitoxantrone for acute leukemia]S Oguma, Y Tatsumi, F Hirayama, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1988
Immunologic abnormality in NZB/NZW F1 mice. Thymus-independent occurrence of B cell abnormality and requirement for T cells in the development of autoimmune disease, as evidenced by an analysis of the athymic nude individualsM Mihara, Y Ohsugi, K Saito, et al.
Immunology|October 1, 1989
Different effect of prostaglandin E2 on B-cell activation by two distinct B-cell differentiation factors, B151-TRF1/IL-5 and B151-TRF2: selective inhibition of B151-TRF2-induced antibody response through increases in intracellular cyclic AMP levelsK Ishihara, S Ono, Y Takahama, et al.
Cancer Gene Therapy|March 10, 2012
Potential use of folate-polyethylene glycol (PEG)-appended dendrimer (G3) conjugate with α-cyclodextrin as DNA carriers to tumor cellsH Arima, M Arizono, T Higashi, et al.
Blood|July 29, 1998
Different adhesive characteristics and VLA-4 expression of CD34(+) progenitors in G0/G1 versus S+G2/M phases of the cell cycleM Yamaguchi, K Ikebuchi, F Hirayama, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics|July 1, 1985
[Infectious complications and infection prevention in patients with acute leukemia]H Teshima, Y Kanakura, K Ishihara, et al.
Chemical & Pharmaceutical Bulletin|August 1, 1993
Inclusion complexation of p-hydroxybenzoic acid esters with 2-hydroxypropyl-beta-cyclodextrins. On changes in solubility and antimicrobial activityH Matsuda, K Ito, Y Sato, et al.
The Japanese Journal of Antibiotics|September 1, 1985
[Therapeutic effectiveness of aztreonam on severe infections associated with hematologic disorders. Hanshin Infection Study Group]F Hirayama, T Masaoka, H Shibata, et al.
Japanese Journal of Clinical Oncology|December 1, 1984
In vitro treatment of human acute lymphocytic leukemia cells in bone marrow with a cocktail of monoclonal antibodiesH Nakamura, F Hirayama, Y Tatsumi, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Thrombosis and Haemostasis|April 8, 1998
Biochemical and pharmacological characterization of YM-60828, a newly synthesized and orally active inhibitor of human factor XaY Taniuchi, Y Sakai, N Hisamichi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1984
[Phase II study of mitoxantrone for acute leukemia]S Oguma, Y Tatsumi, F Hirayama, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1988
Immunologic abnormality in NZB/NZW F1 mice. Thymus-independent occurrence of B cell abnormality and requirement for T cells in the development of autoimmune disease, as evidenced by an analysis of the athymic nude individualsM Mihara, Y Ohsugi, K Saito, et al.
Immunology|October 1, 1989
Different effect of prostaglandin E2 on B-cell activation by two distinct B-cell differentiation factors, B151-TRF1/IL-5 and B151-TRF2: selective inhibition of B151-TRF2-induced antibody response through increases in intracellular cyclic AMP levelsK Ishihara, S Ono, Y Takahama, et al.
Cancer Gene Therapy|March 10, 2012
Potential use of folate-polyethylene glycol (PEG)-appended dendrimer (G3) conjugate with α-cyclodextrin as DNA carriers to tumor cellsH Arima, M Arizono, T Higashi, et al.
Blood|July 29, 1998
Different adhesive characteristics and VLA-4 expression of CD34(+) progenitors in G0/G1 versus S+G2/M phases of the cell cycleM Yamaguchi, K Ikebuchi, F Hirayama, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics|July 1, 1985
[Infectious complications and infection prevention in patients with acute leukemia]H Teshima, Y Kanakura, K Ishihara, et al.
Chemical & Pharmaceutical Bulletin|August 1, 1993
Inclusion complexation of p-hydroxybenzoic acid esters with 2-hydroxypropyl-beta-cyclodextrins. On changes in solubility and antimicrobial activityH Matsuda, K Ito, Y Sato, et al.
The Japanese Journal of Antibiotics|September 1, 1985
[Therapeutic effectiveness of aztreonam on severe infections associated with hematologic disorders. Hanshin Infection Study Group]F Hirayama, T Masaoka, H Shibata, et al.
Japanese Journal of Clinical Oncology|December 1, 1984
In vitro treatment of human acute lymphocytic leukemia cells in bone marrow with a cocktail of monoclonal antibodiesH Nakamura, F Hirayama, Y Tatsumi, et al.
Pageof 13